Cetera Investment Advisers
NUTX

Cetera Investment Advisers’s Nutex Health NUTX Stock Holding History

Cetera Investment Advisers’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$830K Sell
4,856
-672
-12% -$85.1K ﹤0.01% 3214
2026
Q1 		$525K Sell
5,528
-3,074
-36% -$377K ﹤0.01% 3466
2025
Q4 		$1.42M Buy
8,602
+5,700
+196% +$756K ﹤0.01% 2527
2025
Q3 		$300K Buy
+2,902
New +$285K ﹤0.01% 3834
2024
Q2 		– Sell
-67
Closed -$966 – 3821
2024
Q1 		$966 Hold
67
– – ﹤0.01% 3677
2023
Q4 		$1.8K Hold
67
– – ﹤0.01% 2220
2023
Q3 		$2.02K Hold
67
– – ﹤0.01% 2185
2023
Q2 		$4.22K Hold
67
– – ﹤0.01% 2171
2023
Q1 		$10.1K Hold
67
– – ﹤0.01% 2137
2022
Q4 		$19K Buy
+67
New +$12.9K ﹤0.01% 2064
2022
Q3 		– Sell
-67
Closed -$32K – 1834
2022
Q2 		$32K Buy
+67
New +$79K ﹤0.01% 1788

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Cetera Investment Advisers's NUTX Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Nutex Health (NUTX) stake by 12% in Q2 2026, selling an estimated $85.1K and leaving 4,856 shares worth $830K. The position accounts for ﹤0.01% of the portfolio, ranked #3214.

Cetera Investment Advisers first reported a position in NUTX in Q2 2022 and has held it in 11 quarters since. The position peaked at $1.42M in Q4 2025. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Cetera Investment Advisers held 4,856 shares of Nutex Health worth $830K as of Q2 2026.
  • Cetera Investment Advisers sold 672 Nutex Health shares in Q2 2026, an estimated $85.1K.
  • Nutex Health made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3214 holding.
  • Cetera Investment Advisers first reported a position in Nutex Health in Q2 2022 and has held it in 11 quarters since.
  • Cetera Investment Advisers's Nutex Health position peaked at $1.42M in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.